title: Systemic tumor-specific gene delivery.
abstract: The objective of a systemically administered cancer gene therapy is to achieve gene expression that is isolated to the tumor tissue. Unfortunately, viral systems have strong affinity for the liver, and delivery from non-viral cationic systems often results in high expression in the lungs. Non-specific delivery to these organs must be overcome if tumors are to be aggressively treated with genes such as IL-12 which activates a tumor immune response, and TNF-alpha which can induce tumor cell apoptosis. Techniques which have led to specific expression in tumor tissue include receptor targeting through ligand conjugation, utilization of tumor specific promoters and viral mutation in order to take advantage of proteins overexpressed in tumor cells. This review analyzes these techniques applied to liposomal, PEI, dendrimer, stem cell and viral gene delivery systems in order to determine the techniques that are most effective in achieving tumor specific gene expression after systemic administration.
authors.affiliation: Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, 12850 Montview Boulevard, Aurora, Colorado 80045, USA. Electronic address: max.kullberg@ucdenver.edu.
authors.forename: Max
authors.initials: M
authors.lastname: Kullberg
authors.forename: Ryan
authors.initials: R
authors.lastname: McCarthy
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Anchordoquy
mesh_terms: D000818:Animals; D050091:Dendrimers / Q000737:chemistry; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D008081:Liposomes / Q000737:chemistry; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D011094:Polyethyleneimine / Q000737:chemistry; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use; D014780:Viruses / Q000235:genetics
chemical_list: D050091:Dendrimers; D008081:Liposomes; D034741:RNA, Small Interfering; D011094:Polyethyleneimine
keywords: Delivery system; Dendrimer; Gene therapy; Non-viral; Systemic; Viral
references.citation: Hepatology. 2002 Nov;36(5):1106-14
references.pmid: 12395320
references.citation: Biomaterials. 2011 Feb;32(5):1370-6
references.pmid: 21074847
references.citation: Hepatology. 2007 Nov;46(5):1498-508
references.pmid: 17705261
references.citation: J Natl Cancer Inst. 2005 Apr 6;97(7):540-1; author reply 541-2
references.pmid: 15812081
references.citation: J Control Release. 2008 Dec 8;132(2):131-40
references.pmid: 18812195
references.citation: Stem Cells. 2007 Jul;25(7):1618-26
references.pmid: 17412895
references.citation: J Pharm Sci. 2008 Jan;97(1):237-50
references.pmid: 17721944
references.citation: Cancer. 2009 Jan 1;115(1):13-22
references.pmid: 19051291
references.citation: Biomaterials. 2012 Jan;33(1):270-82
references.pmid: 21963149
references.citation: Cancer Lett. 2006 May 8;236(1):58-63
references.pmid: 15953675
references.citation: Expert Opin Drug Deliv. 2009 Dec;6(12):1351-61
references.pmid: 19780710
references.citation: Hum Gene Ther. 2005 Aug;16(8):937-46
references.pmid: 16076252
references.citation: Biomaterials. 2013 Sep;34(28):6976-91
references.pmid: 23777916
references.citation: Cancer Gene Ther. 2010 May;17(5):334-43
references.pmid: 20075981
references.citation: Curr Stem Cell Res Ther. 2009 Jan;4(1):44-9
references.pmid: 19149629
references.citation: Folia Histochem Cytobiol. 2012 Oct 08;50(3):414-9
references.pmid: 23042272
references.citation: Clin Transl Oncol. 2011 Dec;13(12):839-47
references.pmid: 22126726
references.citation: Mol Pharm. 2011 Oct 3;8(5):1480-7
references.pmid: 21755953
references.citation: J Control Release. 2003 Aug 28;91(1-2):173-81
references.pmid: 12932649
references.citation: Cancer Res. 2007 Sep 1;67(17):8301-6
references.pmid: 17804745
references.citation: Trends Mol Med. 2002;8(4 Suppl):S68-73
references.pmid: 11927291
references.citation: FASEB J. 2010 Jul;24(7):2301-13
references.pmid: 20203088
references.citation: J Natl Cancer Inst. 2004 Nov 3;96(21):1593-603
references.pmid: 15523088
references.citation: J Radiat Res. 2012 Jul;53(4):506-15
references.pmid: 22843615
references.citation: J Pharm Sci. 2011 Jan;100(1):38-52
references.pmid: 20575003
references.citation: Nat Med. 2005 Mar;11(3):346-52
references.pmid: 15711560
references.citation: Hum Gene Ther. 2006 Oct;17(10):997-1005
references.pmid: 17032155
references.citation: Int J Pharm. 2012 May 1;427(1):3-20
references.pmid: 21798324
references.citation: Cancer Treat Res. 2006;130:141-65
references.pmid: 16610707
references.citation: Ann Surg. 1999 Sep;230(3):352-60; discussion 360-1
references.pmid: 10493482
references.citation: RNA. 2013 Jun;19(6):767-77
references.pmid: 23604636
references.citation: Gene Ther. 2001 Jan;8(1):28-40
references.pmid: 11402299
references.citation: Hepatology. 2011 Dec;54(6):2036-47
references.pmid: 21898499
references.citation: Cancer Res. 1999 Sep 15;59(18):4668-74
references.pmid: 10493523
references.citation: Cytotherapy. 2009;11(5):516-26
references.pmid: 19562576
references.citation: Bioconjug Chem. 2009 Mar 18;20(3):518-32
references.pmid: 19228071
references.citation: Cancer Res. 2013 Jan 1;73(1):364-72
references.pmid: 23066037
references.citation: J Natl Cancer Inst. 1999 Oct 20;91(20):1744-50
references.pmid: 10528025
references.citation: Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9747-51
references.pmid: 7568210
references.citation: J Gene Med. 2009 Jun;11(6):535-44
references.pmid: 19326369
references.citation: Curr Mol Med. 2006 May;6(3):339-49
references.pmid: 16712479
references.citation: Cancer Res. 2002 Jul 1;62(13):3603-8
references.pmid: 12097260
references.citation: J Interferon Cytokine Res. 2006 Sep;26(9):593-608
references.pmid: 16978064
references.citation: Biomaterials. 2013 Sep;34(27):6429-43
references.pmid: 23727262
references.citation: J Control Release. 2002 Aug 21;82(2-3):183-7
references.pmid: 12175736
references.citation: Adv Drug Deliv Rev. 2012 Dec;64(15):1749-58
references.pmid: 22634161
references.citation: Biomacromolecules. 2010 Sep 13;11(9):2221-9
references.pmid: 20704346
references.citation: Curr Gene Ther. 2011 Oct;11(5):423-32
references.pmid: 21711227
references.citation: Mol Ther. 2013 Feb;21(2):358-67
references.pmid: 23229091
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: Bioconjug Chem. 2003 Jan-Feb;14(1):222-31
references.pmid: 12526712
references.citation: Int J Pharm. 2012 Sep 15;434(1-2):9-19
references.pmid: 22617794
references.citation: Vaccine. 2010 May 21;28(23):3883-7
references.pmid: 20371389
references.citation: Eur J Pharm Sci. 2010 Jun 14;40(3):159-70
references.pmid: 20359532
references.citation: Gene Ther. 2009 Jul;16(7):905-15
references.pmid: 19440231
references.citation: J Pathol. 2006 Jan;208(2):299-318
references.pmid: 16362990
references.citation: Mol Ther. 2007 Apr;15(4):713-20
references.pmid: 17299407
references.citation: Mol Med Rep. 2012 Jul;6(1):9-15
references.pmid: 22576734
references.citation: Cancer Res. 2005 Sep 15;65(18):8079-84
references.pmid: 16166279
references.citation: J Immunol. 2011 Jul 15;187(2):597-602
references.pmid: 21734079
references.citation: Int J Nanomedicine. 2010 Aug 09;5:371-83
references.pmid: 20957159
references.citation: Mol Ther. 2013 Apr;21(4):758-66
references.pmid: 23319057
references.citation: Adv Drug Deliv Rev. 2005 Dec 14;57(15):2177-202
references.pmid: 16310284
references.citation: Cell Death Dis. 2011 Feb 24;2:e121
references.pmid: 21368892
references.citation: Cancer Gene Ther. 2000 Jan;7(1):66-73
references.pmid: 10678358
references.citation: J Control Release. 2010 Apr 19;143(2):215-21
references.pmid: 19944722
references.citation: J Gene Med. 2009 May;11(5):373-81
references.pmid: 19274675
references.citation: Expert Opin Drug Deliv. 2013 Feb;10(2):215-28
references.pmid: 23252504
references.citation: J Control Release. 2010 Aug 17;146(1):99-105
references.pmid: 20438778
references.citation: J Pharm Pharm Sci. 2010;13(3):472-85
references.pmid: 21092717
references.citation: Cancer Res. 2009 Mar 15;69(6):2655-62
references.pmid: 19258509